MediPharm Labs Corp. (OTCMKTS:MEDIF) Stock Drops 15%: Successfully Completes the Sale of its Australian Facility

October 10, 2022

MediPharm Labs Corp. (OTCMKTS:MEDIF), which specializes in precision-based cannabinoids, has announced on October 7, 2022, about completing the sale of MediPharm Labs Australia Pty, its fully owned subsidiary. Trading Data      On Friday, MEDIF stock slumped 14.63% to $0.0560 with more than 41.19K shares, compared to volume of 93.63K shares. The stock moved within a range of $0.0559 – 0.0703 after opening trade at $0.0703. MediPharm Labs Completes Sale of Australian…